Elixir has spud CSG well amid management’s high expectations

|

Published 10-JUL-2020 09:40 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Elixir Energy Limited (ASX:EXR) has advised that the much anticipated Nomgon-2 appraisal core-hole well was spud last night with management expecting it to reach total depth by the end of July or early August.

Elixir Energy is a gas exploration company focused on the 100% owned Nomgon IX coal-bed methane (CBM) production sharing contract (PSC) located in the South of Mongolia, proximate to the Chinese border.

The 30,000 square kilometre PSC was executed in September 2018 and has an exploration period of more than 10 years.

The Nomgon-2 well is intended to produce a similar suite of test results as its predecessor Nomgon-1.

These results will become progressively available after the well reaches its target depth and samples are either analysed on-site or sent to laboratories in Mongolia and China.

The company’s seismic contractor commenced the acquisition of 2D seismic on June 30 in the north-west part of the licence area.

The total 106 kilometre acquisition program should be finished by early August and subsequent processing will take around another month after that.

New areas of outcropping coal identified

Recent field work and data collection and analysis has identified new areas of coal outcropping in various parts of the PSC area.

The location of these is consistent with Elixir’s prospective resource estimates.

They support the view that the very large licence area is likely to host numerous coal bearing sub-basins that are prospective for coal seam gas.

Summing up his expectations regarding upcoming exploration activity, Young said, “Our appraisal and exploration program has now started in line with our plans and we look forward to receiving the results which will be integrated with the results of Nomgon-1 over the rest of this year.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X